Biopharmaceutical Company Xenome Ltd Today Announced The Appointment Of Michael Aldridge As Executive Director
5/25/2010 1:38:25 PM
More...
|
Xenome Ltd Licenses Peptides from xdiscoverTM Library to MedImmune
3/23/2010 2:23:23 PM
More...
|
Dr Julie Cherrington Joins Xenome Ltd Board
8/11/2009 12:07:26 PM
More...
|
Xenome Ltd And Axxam srl Initiate Discovery Partnership Focused On Novel Peptides Against GPCR Targets
8/11/2009 12:05:16 PM
More...
|
Xenome Ltd Release: Addition To US Patent Portfolio For Xen2174
4/23/2009 3:03:25 PM
More...
|
Xenome Ltd Grants MedImmune License to xdiscover(TM) Venom Peptide Library
1/8/2009 11:39:32 AM
More...
|
Xenome Ltd Initiates Phase II Clinical Trial Of Xen2174 In Acute Pain
9/26/2008 2:55:56 PM
More...
|
Xenome Ltd Presents Xen2174 Data on Relief of Pain in Cancer Patients
8/21/2008 7:50:44 AM
More...
|
Leading Bioscience Fund GBS Invests $6 Million in Xenome Ltd
7/23/2008 6:51:15 AM
More...
|
Xenome Ltd Appoints Chief Financial Officer
5/28/2008 2:58:40 PM
More...
|
|